Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05306899Phase 3Recruiting

Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches

Role: collaborator

NCT04555278Not ApplicableCompleted

Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain

Role: collaborator

NCT02711085Completed

Modeling Post-traumatic Pain and Recovery: The SYMBIOME Longitudinal Cohort Study

Role: collaborator

NCT01117870Not ApplicableCompleted

Assess the Effectiveness of Pulse RadioFrequency in Patients With Chronic Lumbar Radicular Pain

Role: collaborator

All 4 trials loaded